scholarly article | Q13442814 |
P2093 | author name string | S Morimoto | |
D Uchida | |||
H Toyoda | |||
T Komurasaki | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Structure and function of human amphiregulin: a member of the epidermal growth factor family | Q24292934 | ||
Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor | Q24311299 | ||
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family | Q24314750 | ||
A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF | Q24319855 | ||
Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system | Q24321601 | ||
Heparin-Binding EGF-like Growth Factor: Characterization of Rat and Mouse cDNA Clones, Protein Domain Conservation across Species, and Transcript Expression in Tissues | Q48137309 | ||
Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues | Q48535455 | ||
Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. | Q52517769 | ||
TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. | Q52517773 | ||
Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor | Q53553601 | ||
Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu | Q58212590 | ||
Strain-dependent epithelial defects in mice lacking the EGF receptor | Q58326927 | ||
Induction of transforming growth factor-alpha in activated human alveolar macrophages | Q68092790 | ||
Epidermal growth factor | Q68508116 | ||
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor | Q68811731 | ||
Platelet-derived growth factor | Q68955789 | ||
Expression of epidermal growth factor receptor in human gastric and colonic carcinomas | Q69012326 | ||
Enhancement of wound healing by topical treatment with epidermal growth factor | Q69507377 | ||
Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue | Q69609513 | ||
Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation | Q69846825 | ||
Pathophysiological roles of cytokines in development, immunity, and inflammation | Q72271308 | ||
Identification of heregulin, a specific activator of p185erbB2 | Q24338146 | ||
Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors | Q24339400 | ||
Molecular cloning and expression of an additional epidermal growth factor receptor-related gene | Q24557757 | ||
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury | Q24563035 | ||
The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity | Q24600473 | ||
A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin | Q24603252 | ||
A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs | Q27860573 | ||
Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family | Q28116096 | ||
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype | Q28509173 | ||
Structure, expression and function of a schwannoma-derived growth factor | Q28571901 | ||
Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes | Q28586114 | ||
Patterns of amino acids near signal-sequence cleavage sites | Q29616542 | ||
Signal sequences. The limits of variation | Q29616543 | ||
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat | Q29620254 | ||
Angiogenic factors | Q29620582 | ||
RNA splicing: Three themes with variations | Q30463513 | ||
Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model | Q34238110 | ||
Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors | Q34360598 | ||
ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family | Q34361950 | ||
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene | Q34593947 | ||
Growth factors in development, transformation, and tumorigenesis | Q34659407 | ||
Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor | Q34662007 | ||
The physiology of transforming growth factor-alpha | Q35909651 | ||
Growth factors and cancer | Q36441643 | ||
The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation | Q36550587 | ||
AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). | Q36671510 | ||
Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development | Q36789882 | ||
Peptide growth factors are multifunctional | Q39185300 | ||
Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium | Q40347712 | ||
Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities | Q41216128 | ||
Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta | Q41238288 | ||
Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines | Q41643277 | ||
Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas | Q42207227 | ||
Betacellulin: a mitogen from pancreatic beta cell tumors | Q42811079 | ||
Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines | Q42813360 | ||
Enhancement of epidermal regeneration by biosynthetic epidermal growth factor | Q42938012 | ||
Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit | Q44744920 | ||
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor | Q46766121 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
Epiregulin | Q5383215 | ||
positive regulation of DNA replication | Q14633916 | ||
Epiregulin | Q14914548 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 69-75 | |
P577 | publication date | 1997-08-15 | |
P1433 | published in | Biochemical Journal | Q864221 |
P1476 | title | Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family | |
P478 | volume | 326 ( Pt 1) |
Q38769666 | Alterations in gene expression after gamma-hydroxybutyric acid intake-A pilot study |
Q24793121 | Analysis of VEGF-responsive genes involved in the activation of endothelial cells |
Q37295302 | Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma |
Q44171115 | Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies. |
Q46736635 | Biomedical application of fuzzy association rules for identifying breast cancer biomarkers. |
Q36486683 | Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts |
Q33509293 | Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. |
Q24291006 | Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily |
Q58570118 | Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer |
Q31111797 | Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage |
Q39272792 | Design of peptidomimetics for inhibition of HER2 receptor dimerization by a combination of virtual screening, MD simulations, and QSAR in silico methods |
Q34809415 | Detection of the epidermal growth factor receptor, amphiregulin and epiregulin in formalin-fixed paraffin-embedded human placenta tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging. |
Q43615346 | Differential display and suppressive subtractive hybridization used to identify granulosa cell messenger rna associated with bovine oocyte developmental competence. |
Q37363050 | Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer |
Q99419149 | EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy |
Q40341833 | Effect of epiregulin on pancreatic beta cell growth and insulin secretion. |
Q53414702 | Effects of HB-EGF and epiregulin on wound healing of gingival cells in vitro. |
Q90886378 | Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics |
Q36935651 | Epiregulin (EREG) variation is associated with susceptibility to tuberculosis |
Q24298549 | Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells |
Q37566850 | Epiregulin as a therapeutic target in non-small-cell lung cancer |
Q58549833 | Epiregulin induces leptin secretion and energy expenditure in high-fat diet-fed mice |
Q41039377 | Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes |
Q22001441 | Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin |
Q54389336 | Epiregulin is critical for the acinar cell regeneration of the submandibular gland in a mouse duct ligation model. |
Q37527393 | Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage |
Q27853346 | Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model |
Q92337069 | Epiregulin promotes trophoblast epithelial-mesenchymal transition through poFUT1 and O-fucosylation by poFUT1 on uPA |
Q22253224 | Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes |
Q38196137 | Epiregulin: roles in normal physiology and cancer |
Q37145440 | ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium |
Q34116893 | Growth factors and their receptors in pancreatic cancer |
Q35065342 | High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor |
Q100421594 | Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma |
Q93097802 | Jersey steer ruminal papillae histology and nutrigenomics with diet changes |
Q46070163 | Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control |
Q55096107 | MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells. |
Q36798968 | Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model |
Q35784682 | Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor |
Q24656058 | Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas |
Q37833939 | Non-telomeric activities of telomerase. |
Q35671281 | Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer |
Q39998587 | Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor |
Q47555746 | Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids |
Q27642394 | Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity |
Q38032836 | Telomere lengthening and other functions of telomerase. |
Q33861104 | The EGF domain: requirements for binding to receptors of the ErbB family |
Q29617919 | The ErbB signaling network: receptor heterodimerization in development and cancer |
Q35357793 | The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines |
Q24312466 | The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis |
Q73407461 | Topical epiregulin enhances repair of murine excisional wounds |
Q34267140 | Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells |
Q31117257 | Transcriptome analysis of a human colorectal cancer cell line shows molecular targets of insulin-like growth factor-binding protein-4 overexpression |
Q36895691 | Transformation of polarized epithelial cells by apical mistrafficking of epiregulin |
Q33890477 | X. Trefoil peptide and EGF receptor/ligand transgenic mice |
Search more.